{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:30:55Z","timestamp":1792099855583,"version":"4.4.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T00:00:00Z","timestamp":1434067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12016-015-8494-7","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T12:32:50Z","timestamp":1434025970000},"page":"301-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders"],"prefix":"10.1007","volume":"50","author":[{"given":"Yan","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"key":"8494_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri3570","volume":"14","author":"MR Clark","year":"2014","unstructured":"Clark MR, Mandal M, Ochiai K, Singh H (2014) Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol 14:69\u201380","journal-title":"Nat Rev Immunol"},{"key":"8494_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.04.001","volume":"55","author":"Y Bao","year":"2014","unstructured":"Bao Y, Cao X (2014) The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review. J Autoimmun 55:10\u201323","journal-title":"J Autoimmun"},{"key":"8494_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-med-070912-133235","volume":"65","author":"M Faurschou","year":"2014","unstructured":"Faurschou M, Jayne DR (2014) Anti-B cell antibody therapies for inflammatory rheumatic diseases. Annu Rev Med 65:263\u2013278","journal-title":"Annu Rev Med"},{"key":"8494_CR4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood-2012-01-407742","volume":"121","author":"B Yu","year":"2013","unstructured":"Yu B, Mao Y, Bai LY, Herman SE et al (2013) Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia. Blood 121:136\u2013147","journal-title":"Blood"},{"key":"8494_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3801","volume":"15","author":"MD Cooper","year":"2015","unstructured":"Cooper MD (2015) The early history of B cells. Nat Rev Immunol 15:191\u2013197","journal-title":"Nat Rev Immunol"},{"key":"8494_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-800267-4.00004-3","volume":"122","author":"M Reth","year":"2014","unstructured":"Reth M, Nielsen P (2014) Signaling circuits in early B-cell development. Adv Immunol 122:129\u2013175","journal-title":"Adv Immunol"},{"key":"8494_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS Silva De","year":"2015","unstructured":"De Silva NS, Klein U (2015) Dynamics of B cells in germinal centres. Nat Rev Immunol 15:137\u2013148","journal-title":"Nat Rev Immunol"},{"key":"8494_CR8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.it.2013.03.006","volume":"34","author":"G Li","year":"2013","unstructured":"Li G, Zan H, Xu Z, Casali P (2013) Epigenetics of the antibody response. Trends Immunol 34:460\u2013470","journal-title":"Trends Immunol"},{"key":"8494_CR9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fimmu.2014.00156","volume":"5","author":"MA Choukrallah","year":"2014","unstructured":"Choukrallah MA, Matthias P (2014) The interplay between chromatin and transcription factor networks during B cell development: who pulls the trigger first? Front Immunol 5:156","journal-title":"Front Immunol"},{"key":"8494_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-385991-4.00005-2","volume":"111","author":"J Medvedovic","year":"2011","unstructured":"Medvedovic J, Ebert A, Tagoh H, Busslinger M (2011) Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol 111:179\u2013206","journal-title":"Adv Immunol"},{"key":"8494_CR11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.immuni.2011.06.013","volume":"35","author":"EM Mercer","year":"2011","unstructured":"Mercer EM, Lin YC, Benner C et al (2011) Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 35:413\u2013425","journal-title":"Immunity"},{"key":"8494_CR12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N et al (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576\u2013589","journal-title":"Mol Cell"},{"key":"8494_CR13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.stem.2009.08.016","volume":"5","author":"JJ Trowbridge","year":"2009","unstructured":"Trowbridge JJ, Snow JW, Kim J, Orkin SH (2009) DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 5:442\u2013449","journal-title":"Cell Stem Cell"},{"key":"8494_CR14","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng.463","volume":"41","author":"AM Br\u00f6ske","year":"2009","unstructured":"Br\u00f6ske AM, Vockentanz L, Kharazi S et al (2009) DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet 41:1207\u20131215","journal-title":"Nat Genet"},{"key":"8494_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.1009","volume":"44","author":"GA Challen","year":"2011","unstructured":"Challen GA, Sun D, Jeong M et al (2011) Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 44:23\u201331","journal-title":"Nat Genet"},{"key":"8494_CR16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.exphem.2010.04.004","volume":"38","author":"KY Kong","year":"2010","unstructured":"Kong KY, Owens KS, Rogers JH et al (2010) MIR-23A microRNA cluster inhibits B-cell development. Exp Hematol 38:629\u2013640, e1","journal-title":"Exp Hematol"},{"key":"8494_CR17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/ni1119","volume":"5","author":"H Maier","year":"2004","unstructured":"Maier H, Ostraat R, Gao H et al (2004) Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol 5:1069\u20131077","journal-title":"Nat Immunol"},{"key":"8494_CR18","doi-asserted-by":"crossref","first-page":"11258","DOI":"10.1073\/pnas.0809485106","volume":"106","author":"H Gao","year":"2009","unstructured":"Gao H, Lukin K, Ram\u00edrez J, Fields S, Lopez D, Hagman J (2009) Opposing effects of SWI\/SNF and Mi-2\/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5. Proc Natl Acad Sci U S A 106:11258\u201311263","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR19","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.febslet.2013.05.004","volume":"587","author":"M Zouali","year":"2013","unstructured":"Zouali M (2013) The epigenetic landscape of B lymphocyte tolerance to self. FEBS Lett 587:2067\u20132073","journal-title":"FEBS Lett"},{"key":"8494_CR20","doi-asserted-by":"crossref","first-page":"20395","DOI":"10.1074\/jbc.M701574200","volume":"282","author":"YW Cho","year":"2007","unstructured":"Cho YW, Hong T, Hong S et al (2007) PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem 282:20395\u201320406","journal-title":"J Biol Chem"},{"key":"8494_CR21","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/emboj.2011.140","volume":"30","author":"S McManus","year":"2011","unstructured":"McManus S, Ebert A, Salvagiotto G et al (2011) The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J 30:2388\u20132404","journal-title":"EMBO J"},{"key":"8494_CR22","doi-asserted-by":"crossref","first-page":"35583","DOI":"10.1074\/jbc.M704735200","volume":"282","author":"M Hatta","year":"2007","unstructured":"Hatta M, Cirillo LA (2007) Chromatin opening and stable perturbation of core histone:DNA contacts by FoxO1. J Biol Chem 282:35583\u201335593","journal-title":"J Biol Chem"},{"key":"8494_CR23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ni.1891","volume":"11","author":"YC Lin","year":"2010","unstructured":"Lin YC, Jhunjhunwala S, Benner C et al (2010) A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 11:635\u2013643","journal-title":"Nat Immunol"},{"key":"8494_CR24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.immuni.2010.05.009","volume":"32","author":"S Kuchen","year":"2010","unstructured":"Kuchen S, Resch W, Yamane A et al (2010) Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32:828\u2013839","journal-title":"Immunity"},{"key":"8494_CR25","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1101\/gad.1565607","volume":"21","author":"D O\u2019Carroll","year":"2007","unstructured":"O\u2019Carroll D, Mecklenbrauker I, Das PP et al (2007) A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev 21:1999\u20132004","journal-title":"Genes Dev"},{"key":"8494_CR26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2008.02.020","volume":"132","author":"SB Koralov","year":"2008","unstructured":"Koralov SB, Muljo SA, Galler GR et al (2008) Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132:860\u2013874","journal-title":"Cell"},{"key":"8494_CR27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","volume":"9","author":"C Xiao","year":"2008","unstructured":"Xiao C, Srinivasan L, Calado DP et al (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9:405\u2013414","journal-title":"Nat Immunol"},{"key":"8494_CR28","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1073\/pnas.0702409104","volume":"104","author":"B Zhou","year":"2007","unstructured":"Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF (2007) miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A 104:7080\u20137085","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","volume":"131","author":"C Xiao","year":"2007","unstructured":"Xiao C, Calado DP, Galler G et al (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131:146\u2013159","journal-title":"Cell"},{"key":"8494_CR30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.immuni.2010.06.013","volume":"33","author":"DS Rao","year":"2010","unstructured":"Rao DS, O\u2019Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D (2010) MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 33:48\u201359","journal-title":"Immunity"},{"key":"8494_CR31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","volume":"26","author":"TC Chang","year":"2007","unstructured":"Chang TC, Wentzel EA, Kent OA et al (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:745\u2013752","journal-title":"Mol Cell"},{"key":"8494_CR32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","volume":"26","author":"N Raver-Shapira","year":"2007","unstructured":"Raver-Shapira N, Marciano E, Meiri E et al (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26:731\u2013743","journal-title":"Mol Cell"},{"key":"8494_CR33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.embor.embor904","volume":"4","author":"H Nakase","year":"2003","unstructured":"Nakase H, Takahama Y, Akamatsu Y (2003) Effect of CpG methylation on RAG1\/RAG2 reactivity: implications of direct and indirect mechanisms for controlling V(D)J cleavage. EMBO Rep 4:774\u2013780","journal-title":"EMBO Rep"},{"key":"8494_CR34","doi-asserted-by":"crossref","first-page":"e1001475","DOI":"10.1371\/journal.pbio.1001475","volume":"11","author":"R Selimyan","year":"2013","unstructured":"Selimyan R, Gerstein RM, Ivanova I et al (2013) Localized DNA demethylation at recombination intermediates during immunoglobulin heavy chain gene assembly. PLoS Biol 11:e1001475","journal-title":"PLoS Biol"},{"key":"8494_CR35","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1073\/pnas.150218497","volume":"97","author":"SR Cherry","year":"2000","unstructured":"Cherry SR, Beard C, Jaenisch R, Baltimore D (2000) V(D)J recombination is not activated by demethylation of the kappa locus. Proc Natl Acad Sci U S A 97:8467\u20138472","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4049\/jimmunol.182.3.1362","volume":"182","author":"CR Xu","year":"2009","unstructured":"Xu CR, Feeney AJ (2009) The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling. J Immunol 182:1362\u20131369","journal-title":"J Immunol"},{"key":"8494_CR37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood-2008-02-142786","volume":"112","author":"K Walter","year":"2008","unstructured":"Walter K, Bonifer C, Tagoh H (2008) Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. Blood 112:1673\u20131682","journal-title":"Blood"},{"key":"8494_CR38","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/eji.201343367","volume":"43","author":"M Knoll","year":"2013","unstructured":"Knoll M, Simmons S, Bouquet C, Gr\u00fcn JR, Melchers F (2013) miR-221 redirects precursor B cells to the BM and regulates their residence. Eur J Immunol 43:2497\u20132506","journal-title":"Eur J Immunol"},{"key":"8494_CR39","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2004.05.014","volume":"117","author":"M Kraus","year":"2004","unstructured":"Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K (2004) Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha\/beta heterodimer. Cell 117:787\u2013800","journal-title":"Cell"},{"key":"8494_CR40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","volume":"17","author":"AL Shaffer","year":"2002","unstructured":"Shaffer AL, Lin KI, Kuo TC et al (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51\u201362","journal-title":"Immunity"},{"key":"8494_CR41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.smim.2011.08.010","volume":"23","author":"SL Nutt","year":"2011","unstructured":"Nutt SL, Taubenheim N, Hasbold J, Corcoran LM, Hodgkin PD (2011) The genetic network controlling plasma cell differentiation. Semin Immunol 23:341\u2013349","journal-title":"Semin Immunol"},{"key":"8494_CR42","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1038\/emboj.2010.257","volume":"29","author":"A Muto","year":"2010","unstructured":"Muto A, Ochiai K, Kimura Y et al (2010) Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J 29:4048\u20134061","journal-title":"EMBO J"},{"key":"8494_CR43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1126\/science.276.5312.589","volume":"276","author":"AL Dent","year":"1997","unstructured":"Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM (1997) Control of inflammation, cytokine expression andgerminal center formation by BCL-6. Science 276:589\u2013592","journal-title":"Science"},{"key":"8494_CR44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng0697-161","volume":"16","author":"BH Ye","year":"1997","unstructured":"Ye BH, Cattoretti G, Shen Q et al (1997) The BCL-6 proto-oncogene controlsgerminal-centre formation and Th2-type inflammation. Nat Genet 16:161\u2013170","journal-title":"Nat Genet"},{"key":"8494_CR45","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1084\/jem.192.12.1841","volume":"192","author":"R Reljic","year":"2000","unstructured":"Reljic R, Wagner SD, Peakman LJ, Fearon DT (2000) Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med 192:1841\u20131848","journal-title":"J Exp Med"},{"key":"8494_CR46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","volume":"13","author":"AL Shaffer","year":"2000","unstructured":"Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM (2000) BCL-6 represses genes that function in lymphocyte differentiation, inflammation and cell cycle control. Immunity 13:199\u2013212","journal-title":"Immunity"},{"key":"8494_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cell.2004.09.014","volume":"119","author":"N Fujita","year":"2004","unstructured":"Fujita N, Jaye DL, Geigerman C et al (2004) MTA3 and theMi-2\/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119:75\u201386","journal-title":"Cell"},{"key":"8494_CR48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0092-8674(03)00234-4","volume":"113","author":"N Fujita","year":"2003","unstructured":"Fujita N, Jaye DL, Kajita M et al (2003) MTA3, a Mi-2\/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113:207\u2013219","journal-title":"Cell"},{"key":"8494_CR49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/onc.2013.535","volume":"34","author":"A Batlle-L\u00f3pez","year":"2015","unstructured":"Batlle-L\u00f3pez A, Cortiguera MG, Rosa-Garrido M et al (2015) Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus. Oncogene 34:246\u2013256","journal-title":"Oncogene"},{"key":"8494_CR50","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.1073\/pnas.1004962107","volume":"107","author":"H Ramachandrareddy","year":"2010","unstructured":"Ramachandrareddy H, Bouska A, Shen Y et al (2010) BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells. Proc Natl Acad Sci U S A 107:11930\u201311935","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR51","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/MCB.20.7.2592-2603.2000","volume":"20","author":"J Yu","year":"2000","unstructured":"Yu J, Angelin-Duclos C, Greenwood J, Liao J, Calame K (2000) Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol 20:2592\u20132603","journal-title":"Mol Cell Biol"},{"key":"8494_CR52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1101\/gad.13.1.125","volume":"13","author":"B Ren","year":"1999","unstructured":"Ren B, Chee KJ, Kim TH, Maniatis T (1999) PRDI-BF1\/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev 13:125\u2013137","journal-title":"Genes Dev"},{"key":"8494_CR53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ni1046","volume":"5","author":"I Gyory","year":"2004","unstructured":"Gyory I, Wu J, Fej\u00e9r G, Seto E, Wright KL (2004) PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat Immunol 5:299\u2013308","journal-title":"Nat Immunol"},{"key":"8494_CR54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncb1413","volume":"8","author":"K Ancelin","year":"2006","unstructured":"Ancelin K, Lange UC, Hajkova P et al (2006) Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat Cell Biol 8:623\u2013630","journal-title":"Nat Cell Biol"},{"key":"8494_CR55","doi-asserted-by":"crossref","unstructured":"Su ST, Ying HY, Chiu YK, Lin FR, Chen MY, Lin KI\u00a0(2009) Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation. Mol Cell Biol 29:1421\u20131431","DOI":"10.1128\/MCB.01158-08"},{"key":"8494_CR56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/embor.2012.60","volume":"13","author":"HY Ying","year":"2012","unstructured":"Ying HY, Su ST, Hsu PH et al (2012) SUMOylation of Blimp-1 is critical for plasma cell differentiation. EMBO Rep 13:631\u2013637","journal-title":"EMBO Rep"},{"key":"8494_CR57","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.immuni.2010.11.010","volume":"33","author":"L Belver","year":"2010","unstructured":"Belver L, de Y\u00e9benes VG, Ramiro AR (2010) MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33:713\u2013722","journal-title":"Immunity"},{"key":"8494_CR58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.1141229","volume":"316","author":"TH Thai","year":"2007","unstructured":"Thai TH, Calado DP, Casola S et al (2007) Regulation of the germinal center response by microRNA-155. Science 316:604\u2013608","journal-title":"Science"},{"key":"8494_CR59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, Vigorito E, Clare S et al (2007) Requirement of bic\/microRNA-155 for normal immune function. Science 316:608\u2013611","journal-title":"Science"},{"key":"8494_CR60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","volume":"27","author":"E Vigorito","year":"2007","unstructured":"Vigorito E, Perks KL, Abreu-Goodger C et al (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847\u2013859","journal-title":"Immunity"},{"issue":"5","key":"8494_CR61","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.immuni.2008.04.002","volume":"28","author":"Y Dorsett","year":"2008","unstructured":"Dorsett Y, McBride KM, Jankovic M et al (2008) MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28(5):630\u2013638","journal-title":"Immunity"},{"key":"8494_CR62","doi-asserted-by":"crossref","unstructured":"Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T, Casellas R, Papavasiliou FN. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28:621\u2013629","DOI":"10.1016\/j.immuni.2008.03.015"},{"key":"8494_CR63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.immuni.2007.12.004","volume":"28","author":"MJ Shlomchik","year":"2008","unstructured":"Shlomchik MJ (2008) Sites and stages of autoreactive B cell activation and regulation. Immunity 28:18\u201328","journal-title":"Immunity"},{"key":"8494_CR64","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri2637","volume":"9","author":"CG Vinuesa","year":"2009","unstructured":"Vinuesa CG, Sanz I, Cook MC (2009) Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 9:845\u2013857","journal-title":"Nat Rev Immunol"},{"key":"8494_CR65","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1074-7613(00)80286-1","volume":"6","author":"M Hertz","year":"1997","unstructured":"Hertz M, Nemazee D (1997) BCR ligation induces receptor editing in IgM\u2009+\u2009IgD- bone marrow B cells in vitro. Immunity 6:429\u2013436","journal-title":"Immunity"},{"key":"8494_CR66","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.94.17.9267","volume":"94","author":"D Melamed","year":"1997","unstructured":"Melamed D, Nemazee D (1997) Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci U S A 94:9267\u20139272","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR67","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1073\/pnas.0610434104","volume":"104","author":"L Mazari","year":"2007","unstructured":"Mazari L, Ouarzane M, Zouali M (2007) Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc Natl Acad Sci U S A 104:6317\u20136322","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/icb.2015.18","volume":"93","author":"B Gupta","year":"2015","unstructured":"Gupta B, Hawkins RD (2015) Epigenomics of autoimmune diseases. Immunol Cell Biol 93:271\u2013276","journal-title":"Immunol Cell Biol"},{"key":"8494_CR69","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.4049\/jimmunol.0802412","volume":"182","author":"S Garaud","year":"2009","unstructured":"Garaud S, Le Dantec C, Jousse-Joulin S et al (2009) IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 182:5623\u20135632","journal-title":"J Immunol"},{"key":"8494_CR70","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.4049\/jimmunol.178.11.6941","volume":"178","author":"N Forster","year":"2007","unstructured":"Forster N, Gallinat S, Jablonska J, Weiss S, Els\u00e4sser HP, Lutz W (2007) p300 protein acetyltransferase activity suppresses systemic lupus erythematosus-like autoimmune disease in mice. J Immunol 178:6941\u20136948","journal-title":"J Immunol"},{"key":"8494_CR71","doi-asserted-by":"crossref","first-page":"20194","DOI":"10.1073\/pnas.1317632110","volume":"110","author":"TH Thai","year":"2013","unstructured":"Thai TH, Patterson HC, Pham DH, Kis-Toth K, Kaminski DA, Tsokos GC (2013) Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse. Proc Natl Acad Sci U S A 110:20194\u201320199","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cei.12265","volume":"176","author":"YZ Wang","year":"2014","unstructured":"Wang YZ, Tian FF, Yan M et al (2014) Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis. Clin Exp Immunol 176:207\u2013221","journal-title":"Clin Exp Immunol"},{"key":"8494_CR73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/imm.12347","volume":"144","author":"J Zhang","year":"2015","unstructured":"Zhang J, Jia G, Liu Q et al (2015) Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis. Immunology 144:56\u201367","journal-title":"Immunology"},{"key":"8494_CR74","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.1301289","volume":"191","author":"Y Mok","year":"2013","unstructured":"Mok Y, Schwierzeck V, Thomas DC et al (2013) MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production. J Immunol 191:3037\u20133048","journal-title":"J Immunol"},{"key":"8494_CR75","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard.2010.139857","volume":"70","author":"E Stagakis","year":"2011","unstructured":"Stagakis E, Bertsias G, Verginis P et al (2011) Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 70:1496\u20131506","journal-title":"Ann Rheum Dis"},{"key":"8494_CR76","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.4049\/jimmunol.0904060","volume":"184","author":"W Pan","year":"2010","unstructured":"Pan W, Zhu S, Yuan M et al (2010) MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184:6773\u20136781","journal-title":"J Immunol"},{"key":"8494_CR77","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/emmm.201100171","volume":"3","author":"BG Garchow","year":"2011","unstructured":"Garchow BG, Bartulos Encinas O, Leung YT et al (2011) Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol Med 3:605\u2013615","journal-title":"EMBO Mol Med"},{"key":"8494_CR78","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molimm.2012.04.007","volume":"52","author":"Y Yuan","year":"2012","unstructured":"Yuan Y, Kasar S, Underbayev C et al (2012) Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus. Mol Immunol 52:61\u201370","journal-title":"Mol Immunol"},{"key":"8494_CR79","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/art.37912","volume":"65","author":"Y Liu","year":"2013","unstructured":"Liu Y, Dong J, Mu R et al (2013) MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum 65:1603\u20131611","journal-title":"Arthritis Rheum"},{"key":"8494_CR80","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/art.23429","volume":"58","author":"T Nakasa","year":"2008","unstructured":"Nakasa T, Miyaki S, Okubo A et al (2008) Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 58:1284\u20131292","journal-title":"Arthritis Rheum"},{"key":"8494_CR81","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/2011\/304852","volume":"30","author":"G Wang","year":"2011","unstructured":"Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC (2011) Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers 30:171\u2013179","journal-title":"Dis Markers"},{"key":"8494_CR82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein U, Dalla-Favera R (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8:22\u201333","journal-title":"Nat Rev Immunol"},{"key":"8494_CR83","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman MA, Lawrence MS, Keats JJ et al (2011) Initial genome sequencing and analysis of multiple myeloma. Nature 471:467\u2013472","journal-title":"Nature"},{"key":"8494_CR84","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476:298\u2013303","journal-title":"Nature"},{"key":"8494_CR85","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1182\/blood-2010-04-280149","volume":"116","author":"I Velichutina","year":"2010","unstructured":"Velichutina I, Shaknovich R, Geng H et al (2010) EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 116:5247\u20135255","journal-title":"Blood"},{"key":"8494_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.164.1.1","volume":"164","author":"FM Raaphorst","year":"2000","unstructured":"Raaphorst FM, van Kemenade FJ, Fieret E et al (2000) Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J Immunol 164:1\u20134","journal-title":"J Immunol"},{"key":"8494_CR87","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood.V97.12.3896","volume":"97","author":"FJ Kemenade van","year":"2001","unstructured":"van Kemenade FJ, Raaphorst FM, Blokzijl T et al (2001) Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 97:3896\u20133901","journal-title":"Blood"},{"key":"8494_CR88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM et al (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42:181\u2013185","journal-title":"Nat Genet"},{"key":"8494_CR89","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/leu.2010.311","volume":"25","author":"C B\u00f6d\u00f6r","year":"2011","unstructured":"B\u00f6d\u00f6r C, O\u2019Riain C, Wrench D et al (2011) EZH2 Y641 mutations in follicular lymphoma. Leukemia 25:726\u2013729","journal-title":"Leukemia"},{"key":"8494_CR90","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1172\/JCI70626","volume":"123","author":"M Caganova","year":"2013","unstructured":"Caganova M, Carrisi C, Varano G et al (2013) Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. J Clin Invest 123:5009\u20135022","journal-title":"J Clin Invest"},{"key":"8494_CR91","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W Beguelin","year":"2013","unstructured":"Beguelin W, Popovic R, Teater M et al (2013) EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23:677\u2013692","journal-title":"Cancer Cell"},{"key":"8494_CR92","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","volume":"492","author":"MT McCabe","year":"2012","unstructured":"McCabe MT, Ott HM, Ganji G et al (2012) EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492:108\u2013112","journal-title":"Nature"},{"key":"8494_CR93","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","volume":"8","author":"SK Knutson","year":"2012","unstructured":"Knutson SK, Wigle TJ, Warholic NM et al (2012) A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol 8:890\u2013896","journal-title":"Nat Chem Biol"},{"key":"8494_CR94","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A et al (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471:189\u2013195","journal-title":"Nature"},{"key":"8494_CR95","doi-asserted-by":"crossref","unstructured":"Cerchietti LC, Hatzi K, Caldas-Lopes E et al (2010) BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy. J Clin Invest pii: 42869. doi: 10.1172\/JCI42869 . [Epub ahead of print]","DOI":"10.1172\/JCI42869"},{"key":"8494_CR96","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1182\/blood-2008-07-168773","volume":"113","author":"LC Cerchietti","year":"2009","unstructured":"Cerchietti LC, Yang SN, Shaknovich R et al (2009) A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood 113:3397\u20133405","journal-title":"Blood"},{"key":"8494_CR97","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1182\/blood-2012-06-437624","volume":"120","author":"L Giulino-Roth","year":"2012","unstructured":"Giulino-Roth L, Wang K, MacDonald TY et al (2012) Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood 120:5181\u20135184","journal-title":"Blood"},{"key":"8494_CR98","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","volume":"44","author":"V Quesada","year":"2011","unstructured":"Quesada V, Conde L, Villamor N et al (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44:47\u201352","journal-title":"Nat Genet"},{"key":"8494_CR99","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.2246","volume":"44","author":"ZJ Zang","year":"2012","unstructured":"Zang ZJ, Cutcutache I, Poon SL et al (2012) Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 44:570\u2013574","journal-title":"Nat Genet"},{"key":"8494_CR100","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","volume":"71","author":"B Guan","year":"2011","unstructured":"Guan B, Wang TL, Shih IM (2011) ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 71:6718\u20136127","journal-title":"Cancer Res"},{"key":"8494_CR101","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/emboj.2012.136","volume":"31","author":"A Harada","year":"2012","unstructured":"Harada A, Okada S, Konno D et al (2012) Chd2 interacts with H3.3 to determine myogenic cell fate. EMBO J 31:2994\u20133007","journal-title":"EMBO J"},{"key":"8494_CR102","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/onc.2008.440","volume":"28","author":"P Nagarajan","year":"2009","unstructured":"Nagarajan P, Onami TM, Rajagopalan S, Kania S, Donnell R, Venkatachalam S (2009) Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis. Oncogene 28:1053\u20131062","journal-title":"Oncogene"},{"key":"8494_CR103","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524\u201315529","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR104","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910\u20131916","journal-title":"N Engl J Med"},{"key":"8494_CR105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","volume":"359","author":"AC Rawstron","year":"2008","unstructured":"Rawstron AC, Bennett FL, O\u2019Connor SJ et al (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359:575\u2013583","journal-title":"N Engl J Med"},{"key":"8494_CR106","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","volume":"94","author":"H Avet-Loiseau","year":"1999","unstructured":"Avet-Loiseau H, Li JY, Morineau N et al (1999) Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome. Blood 94:2583\u20132589","journal-title":"Blood"},{"key":"8494_CR107","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","volume":"17","author":"U Klein","year":"2010","unstructured":"Klein U, Lia M, Crespo M et al (2010) The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17:28\u201340","journal-title":"Cancer Cell"},{"key":"8494_CR108","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M et al (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102:13944\u201313949","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR109","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM, Hemann MT et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828\u2013833","journal-title":"Nature"},{"key":"8494_CR110","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","volume":"103","author":"S Costinean","year":"2006","unstructured":"Costinean S, Zanesi N, Pekarsky Y et al (2006) Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 103:7024\u20137029","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR111","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1084\/jem.20121387","volume":"209","author":"K Basso","year":"2012","unstructured":"Basso K, Schneider C, Shen Q et al (2012) BCL6 positively regulates AID and germinal center gene expression via repression of miR-155. J Exp Med 209:2455\u20132465","journal-title":"J Exp Med"},{"key":"8494_CR112","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.20273","volume":"45","author":"J Kluiver","year":"2006","unstructured":"Kluiver J, Haralambieva E, de Jong D et al (2006) Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosom Cancer 45:147\u2013153","journal-title":"Genes Chromosom Cancer"},{"key":"8494_CR113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","volume":"207","author":"J Kluiver","year":"2005","unstructured":"Kluiver J, Poppema S, de Jong D et al (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207:243\u2013249","journal-title":"J Pathol"},{"key":"8494_CR114","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"PS Eis","year":"2005","unstructured":"Eis PS, Tam W, Sun L et al (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102:3627\u20133632","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR115","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1101\/gad.1861409","volume":"23","author":"V Olive","year":"2009","unstructured":"Olive V, Bennett MJ, Walker JC et al (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23:2839\u20132849","journal-title":"Genes Dev"},{"key":"8494_CR116","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.0914900107","volume":"107","author":"S Mi","year":"2010","unstructured":"Mi S, Li Z, Chen P et al (2010) Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc Natl Acad Sci U S A 107:3710\u2013371","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8494_CR117","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","volume":"23","author":"P Mu","year":"2009","unstructured":"Mu P, Han YC, Betel D et al (2009) Genetic dissection of the miR-17\u2009\u223c\u200992 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23:2806\u20132811","journal-title":"Genes Dev"},{"key":"8494_CR118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.1887110","volume":"24","author":"G Haaften Van","year":"2010","unstructured":"Van Haaften G, Agami R (2010) Tumorigenicity of the miR-17-92 cluster distilled. Genes Dev 24:1\u20134","journal-title":"Genes Dev"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8494-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8494-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8494-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T09:07:05Z","timestamp":1599124025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8494-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["8494"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8494-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}